Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Vincristine in Veterinary Oncology: IV Safety and Monitoring
Vincristine is a vinca alkaloid used within selected veterinary chemotherapy protocols and requires precise intravenous administration and protocol-specific monitoring.
Read more
Cyclophosphamide in Cancer Protocols: Bladder and Marrow Safety
Cyclophosphamide is an alkylating chemotherapy used in selected veterinary protocols, with blood-count, urinary, gastrointestinal, and household-safety considerations.
Read more
Vinblastine in Veterinary Oncology: Protocol and Extravasation Awareness
Vinblastine is an intravenous vinca alkaloid used in selected veterinary protocols and demands venous, blood-count, gastrointestinal, and interaction monitoring.
Read more
Chlorambucil: Oral Chemotherapy Is Still Hazardous Medicine
Chlorambucil is an oral alkylating chemotherapy used in selected slow-growing blood cancers and other protocols, with cumulative marrow and handling considerations.
Read more
Melphalan in Veterinary Oncology: Cumulative Marrow-Risk Discussion
Melphalan is an alkylating antineoplastic medicine used in selected veterinary cancers and requires individualized blood-count, gastrointestinal, and handling plans.
Read more
Mitoxantrone in Veterinary Oncology: Infusion and Blood-Count Profile
Mitoxantrone is an intravenous antineoplastic medicine used in selected canine and feline protocols, with infusion, marrow, and gastrointestinal monitoring.
Read more
Gemcitabine in Veterinary Oncology: Limited and Protocol-Specific Evidence
Gemcitabine is an intravenous antimetabolite considered in selected veterinary protocols, where evidence and toxicity must be reviewed for the exact diagnosis.
Read more
Methotrexate in Veterinary Oncology: Interaction and Organ-Safety Review
Methotrexate is a folate-antagonist antimetabolite with selected veterinary uses and clinically important marrow, gastrointestinal, liver, lung, and interaction considerations.
Read more
Cytarabine in Veterinary Cancer Care: Route and Marrow Monitoring
Cytarabine is an antimetabolite used in selected veterinary hematologic or central nervous system protocols, with route- and schedule-specific monitoring.
Read more
Taxane Chemotherapy: Formulation, Infusion, and Evidence Questions
Taxanes disrupt microtubule dynamics, but formulation, infusion reactions, species experience, and veterinary evidence differ enough that product names are not interchangeable.
Read more
Metronomic Chemotherapy: Goal, Evidence, and Handling Boundary
Metronomic therapy uses regularly scheduled cytotoxic medication in selected plans; it remains prescription hazardous-drug treatment and is not simply gentle chemotherapy.
Read more
L-Asparaginase in Lymphoid Cancer Protocols
L-asparaginase is an enzyme-based antineoplastic used in selected lymphoma or leukemia protocols, with hypersensitivity and protocol-timing considerations.
Read more